Jul 29, 2026 07:30AM
Jul 6, 2026 07:31AM
Jul 6, 2026 07:30AM
Jun 24, 2026 08:30AM
Jun 9, 2026 07:30AM
Jun 9, 2026 07:30AM
Jun 3, 2026 07:30AM TG Therapeutics reports positive Phase 1 subcutaneous BRIUMVI trial results
Jun 3, 2026 07:30AM
Jun 2, 2026 07:30AM
Jun 1, 2026 07:30AM
Jun 1, 2026 07:30AM
May 28, 2026 07:30AM
May 27, 2026 07:31AM
May 27, 2026 07:30AM TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial
May 26, 2026 07:30AM
May 26, 2026 07:30AM
May 6, 2026 07:00AM
May 5, 2026 07:01AM
Apr 30, 2026 07:30AM
Apr 22, 2026 07:32AM
Apr 22, 2026 07:30AM TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
Apr 15, 2026 07:30AM
Apr 15, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 12, 2026 07:00AM
Mar 9, 2026 07:31AM
Mar 9, 2026 07:30AM Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple Sclerosis
Mar 6, 2026 07:31AM
Mar 6, 2026 07:30AM
Feb 26, 2026 07:00AM
Feb 23, 2026 07:30AM
Feb 17, 2026 07:30AM
Feb 8, 2026 04:17PM
Feb 6, 2026 07:30AM TG Therapeutics presents BRIUMVI data at multiple sclerosis forum
Feb 6, 2026 07:30AM
Jan 27, 2026 07:32AM
Jan 27, 2026 07:30AM
Jan 13, 2026 04:25PM
Jan 13, 2026 04:25PM
Jan 7, 2026 07:30AM
Nov 28, 2025 07:30AM TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
Nov 19, 2025 08:30AM
Nov 10, 2025 04:00PM
Nov 3, 2025 07:00AM
Oct 31, 2025 07:30AM
Oct 28, 2025 07:30AM
Oct 28, 2025 07:30AM
Sep 24, 2025 09:10AM TG Therapeutics reports six-year BRIUMVI data at ECTRIMS conference
Sep 24, 2025 09:10AM

327,057 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All